ENTRY       D09907                      Drug
NAME        Fulranumab (USAN/INN)
FORMULA     C6446H9930N1718O2018S50
EXACT_MASS  145293.325
MOL_WEIGHT  145383.3662
SEQUENCE    (Heavy chain)
            EVQLVESGGG LVQPGGSLRL SCAASGFTLR SYSMNWVRQA PGKGLEWVSY ISRSSHTIFY
            ADSVKGRFTI SRDNAKNSLY LQMDSLRDED TAMYYCARVY SSGWHVSDYF DYWGQGILVT
            VSSASTKGPS VFPLAPCSRS TSESTAALGC LVKDYFPEPV TVSWNSGALT SGVHTFPAVL
            QSSGLYSLSS VVTVPSSNFG TQTYTCNVDH KPSNTKVDKT VERKCCVECP PCPAPPVAGP
            SVFLFPPKPK DTLMISRTPE VTCVVVDVSH EDPEVQFNWY VDGVEVHNAK TKPREEQFNS
            TFRVVSVLTV VHQDWLNGKE YKCKVSNKGL PAPIEKTISK TKGQPREPQV YTLPPSREEM
            TKNQVSLTCL VKGFYPSDIA VEWESNGQPE NNYKTTPPML DSDGSFFLYS KLTVDKSRWQ
            QGNVFSCSVM HEALHNHYTQ KSLSLSPGK
            (Light chain)
            AIQLTQSPSS LSASVGDRVT ITCRASQGIS SALAWYQQKP GKAPKLLIYD ASSLESGVPS
            RFSGSGSGTD FTLTISSLQP EDFATYYCQQ FNSYPLTFGG GTKVEIKRTV AAPSVFIFPP
            SDEQLKSGTA SVVCLLNNFY PREAKVQWKV DNALQSGNSQ ESVTEQDSKD STYSLSSTLT
            LSKADYEKHK VYACEVTHQG LSSPVTKSFN RGEC
            (Disulfide bridge: H22-H96, H150-H206, H263-H323, H369-H427, H225-H'225, H226-H'226, H229-H'229, H232-H'232, L23-L88, L134-L194, H137-L214)
  TYPE      Peptide
EFFICACY    Analgesic, Anti-nerve growth factor antibody
  TYPE      Monoclonal antibody
COMMENT     Treatment of pain
TARGET      NGF [HSA:4803] [KO:K02582]
  PATHWAY   hsa04010(4803)  MAPK signaling pathway
            hsa04210(4803)  Apoptosis
            hsa04722(4803)  Neurotrophin signaling pathway
BRITE       Target-based classification of drugs [BR:br08310]
             Cytokines and receptors
              Cytokines
               Growth factors (RTK-binding)
                NGF
                 D09907  Fulranumab (USAN/INN)
DBLINKS     CAS: 902141-80-4
            PubChem: 124490614
///
